Zatebradine
Alternative Names: ULFS 49; ULFS 49CLLatest Information Update: 03 Mar 2000
At a glance
- Originator Boehringer Ingelheim Pharma KG
- Class Bradycardic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Heart failure; Supraventricular arrhythmias; Ventricular arrhythmias